Updated CRUSADE score to predict in-hospital bleeding: External validation in the Thai percutaneous coronary intervention registry
- PMID: 38219275
- DOI: 10.1002/ccd.30940
Updated CRUSADE score to predict in-hospital bleeding: External validation in the Thai percutaneous coronary intervention registry
Abstract
Background: The Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) score has been recommended to predict in-hospital bleeding risk in non-ST segment elevation myocardial infarction (NSTEMI) patients. The evaluation of the CRUSADE risk score in Asian patients undergoing contemporary percutaneous coronary intervention (PCI) for NSTEMI is necessary.
Aims: We aimed to validate and update the CRUSADE score to predict in-hospital major bleeding in NSTEMI patients treated with PCI.
Method: The Thai PCI registry is a large, prospective, multicenter PCI registry in Thailand enrolling patients between May 2018 and August 2019. The CRUSADE score was calculated based on 8 predictors including sex, diabetes, prior vascular disease (PVD), congestive heart failure (CHF), creatinine clearance (CrCl), hematocrit, systolic blood pressure, and heart rate (HR). The score was fitted to in-hospital major bleeding using the logistic regression. The original score was revised and updated for simplification.
Results: Of 19,701 patients in the Thai PCI registry, 5976 patients presented with NSTEMI. The CRUSADE score was calculated in 5882 patients who had all variables of the score available. Thirty-five percent were female, with a median age of 65.1 years. The proportion of diabetes, PVD, and CHF was 46%, 7.9%, and 11.2%, respectively. The original and revised models of the CRUSADE risk score had C-statistics of 0.817 (95% CI: 0.762-0.871) and 0.839 (95% CI: 0.789-0.889) respectively. The simplified CRUSADE score which contained only four variables (hematocrit, CrCl, HR, and CHF), had C-statistics of 0.837 (0.787-0.886). The calibration of the recalibrated, revised, and simplified model was optimal.
Conclusions: The full and simplified CRUSADE scores performed well in NSTEMI treated with PCI in Thai population.
Keywords: in-hospital bleeding; non-ST segment elevation myocardial infarction; percutaneous coronary intervention; updated CRUSADE score.
© 2024 Wiley Periodicals LLC.
References
REFERENCES
-
- Collet J-P, Thiele H, Barbato E, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2021;42(14):1289-1367.
-
- Subherwal S, Bach RG, Chen AY, et al. Baseline risk of major bleeding in non-ST-segment elevation myocardial infarction. Circulation. 2009;119(14):1873-1882.
-
- Schiele F, Gale CP, Bonnefoy E, et al. Quality indicators for acute myocardial infarction: a position paper of the acute cardiovascular care association. Eur Heart J Acute Cardiovasc Care. 2017;6(1):34-59.
-
- Liu R, Lyu S-Z, Zhao G-Q, et al. Comparison of the performance of the crusade, acuity-horizons, and action bleeding scores in ACS patients undergoing PCI: insights from a cohort of 4939 patients in China. J Geriatr Cardiol. 2017;14(2):93-99.
-
- Simonsson M, Winell H, Olsson H, et al. Development and validation of a novel risk score for in-hospital major bleeding in acute myocardial infarction; The Swedeheart Score. J Am Heart Assoc. 2019;8(5):e012157.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous